| Phase 01 trial |
|
Phase 0
|
NCT04662294 |
Nov 2021 → Jan 2024 overdue |
acute myeloid leukemia, non-Hodgkin lymphoma, plasma cell myeloma |
Zhejiang University |
Recruiting
|
No outcome recorded
|
| Phase 17 trials |
|
Phase 1
|
NCT06326463 |
Oct 2024 → Jul 2030 expected |
childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia, myelodysplastic syndrome |
St. Jude Children's Research Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06215950 |
Jan 2024 → Dec 2026 expected |
cervical cancer, metastatic malignant neoplasm, ovarian cancer |
Chongqing Precision Biotech Co., Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06010875 |
Nov 2023 → Dec 2025 overdue |
cervical cancer, metastatic malignant neoplasm, ovarian cancer, renal cell carcinoma |
Chongqing Precision Biotech Co., Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT05468190 |
Jul 2022 → Jul 2024 |
cervical cancer, metastatic neoplasm, ovarian cancer, renal cell carcinoma |
Chongqing Precision Biotech Co., Ltd |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT05518253 |
May 2022 → May 2026 overdue |
cervical cancer, metastatic neoplasm, ovarian cancer, renal cell carcinoma |
Weijia Fang, MD |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT05420545 |
Dec 2021 → Dec 2023 |
cervical cancer, metastatic neoplasm, ovarian cancer, renal cell carcinoma |
Chongqing Precision Biotech Co., Ltd |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT05420519 |
Dec 2021 → Dec 2023 |
metastatic neoplasm, renal cell carcinoma |
Chongqing Precision Biotech Co., Ltd |
Unknown
|
No outcome recorded
|